These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 7955063)

  • 21. Detection of activated proto-oncogenes in N-nitrosodiethylamine-induced liver tumors: a comparison between B6C3F1 mice and Fischer 344 rats.
    Stowers SJ; Wiseman RW; Ward JM; Miller EC; Miller JA; Anderson MW; Eva A
    Carcinogenesis; 1988 Feb; 9(2):271-6. PubMed ID: 2827904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of protooncogenes in spontaneously occurring non-liver tumors from C57BL/6 x C3H F1 mice.
    Candrian U; You M; Goodrow T; Maronpot RR; Reynolds SH; Anderson MW
    Cancer Res; 1991 Feb; 51(4):1148-53. PubMed ID: 1997158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. H-ras 61st codon activation in archival proliferative hepatic lesions isolated from female B6C3F1 mice exposed to the leukotriene D4-antagonist, LY171883.
    Helvering LM; Richardson FC; Horn DM; Rexroat MA; Engelhardt JA; Richardson KK
    Carcinogenesis; 1994 Feb; 15(2):331-3. PubMed ID: 8313527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporal changes in the mutant frequency and mutation spectra of the 61st codon of the H-ras oncogene following exposure of B6C3F1 mice to N-nitrosodiethylamine (DEN).
    Richardson KK; Rexroat MA; Helvering LM; Copple DM; Richardson FC
    Carcinogenesis; 1992 Jul; 13(7):1277-9. PubMed ID: 1638698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of mutations at codon 61 of the Ha-ras gene in liver tumors of mice genetically susceptible and resistant to hepatocarcinogenesis.
    Dragani TA; Manenti G; Colombo BM; Falvella FS; Gariboldi M; Pierotti MA; Della Porta G
    Oncogene; 1991 Feb; 6(2):333-8. PubMed ID: 2000226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocarcinogenicity of chlordane in B6C3F1 and B6D2F1 male mice: evidence for regression in B6C3F1 mice and carcinogenesis independent of ras proto-oncogene activation.
    Malarkey DE; Devereux TR; Dinse GE; Mann PC; Maronpot RR
    Carcinogenesis; 1995 Nov; 16(11):2617-25. PubMed ID: 7586176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Codon 64 of K-ras gene mutation pattern in hepatocellular carcinomas induced by bleomycin and 1-nitropyrene in A/J mice.
    Bai F; Nakanishi Y; Takayama K; Pei XH; Inoue K; Harada T; Izumi M; Hara N
    Teratog Carcinog Mutagen; 2003; Suppl 1():161-70. PubMed ID: 12616606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ACB-PCR measurement of spontaneous and furan-induced H-ras codon 61 CAA to CTA and CAA to AAA mutation in B6C3F1 mouse liver.
    Banda M; Recio L; Parsons BL
    Environ Mol Mutagen; 2013 Oct; 54(8):659-67. PubMed ID: 24038307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the Ha-ras oncogene in C3H/He mouse liver tumours derived spontaneously or induced with diethylnitrosamine or phenobarbitone.
    Rumsby PC; Barrass NC; Phillimore HE; Evans JG
    Carcinogenesis; 1991 Dec; 12(12):2331-6. PubMed ID: 1747936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased expression of c-myc and c-Ha-ras in dichloroacetate and trichloroacetate-induced liver tumors in B6C3F1 mice.
    Nelson MA; Sanchez IM; Bull RJ; Sylvester SR
    Toxicology; 1990 Oct; 64(1):47-57. PubMed ID: 2219132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations at codon 61 of the Ha-ras proto-oncogene in precancerous liver lesions of the B6C3F1 mouse.
    Buchmann A; Mahr J; Bauer-Hofmann R; Schwarz M
    Mol Carcinog; 1989; 2(3):121-5. PubMed ID: 2675901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in the ras proto-oncogene: clues to etiology and molecular pathogenesis of mouse liver tumors.
    Maronpot RR; Fox T; Malarkey DE; Goldsworthy TL
    Toxicology; 1995 Aug; 101(3):125-56. PubMed ID: 7676462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Point mutations of the c-H-ras gene in spontaneous liver tumors of transgenic mice carrying the human c-H-ras gene.
    Hayashi S; Mori I; Nonoyama T; Mitsumori K
    Toxicol Pathol; 1998; 26(4):556-61. PubMed ID: 9715515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutagenesis of ras proto-oncogenes in rat liver tumors induced by vinyl chloride.
    Froment O; Boivin S; Barbin A; Bancel B; Trepo C; Marion MJ
    Cancer Res; 1994 Oct; 54(20):5340-5. PubMed ID: 7923162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The carcinogenicity of trichloroethylene and its metabolites, trichloroacetic acid and dichloroacetic acid, in mouse liver.
    Herren-Freund SL; Pereira MA; Khoury MD; Olson G
    Toxicol Appl Pharmacol; 1987 Sep; 90(2):183-9. PubMed ID: 3629594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of myc, fos, and Ha-ras in the livers of furan-treated F344 rats and B6C3F1 mice.
    Butterworth BE; Sprankle CS; Goldsworthy SM; Wilson DM; Goldsworthy TL
    Mol Carcinog; 1994 Jan; 9(1):24-32. PubMed ID: 8297482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of ras gene mutations in rainbow trout liver tumors initiated by aflatoxin B1.
    Chang YJ; Mathews C; Mangold K; Marien K; Hendricks J; Bailey G
    Mol Carcinog; 1991; 4(2):112-9. PubMed ID: 1645972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased frequency of K-ras mutations in lung neoplasms from female B6C3F1 mice exposed to ozone for 24 or 30 months.
    Sills RC; Hong HL; Greenwell A; Herbert RA; Boorman GA; Devereux TR
    Carcinogenesis; 1995 Jul; 16(7):1623-8. PubMed ID: 7614698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of heterozygosity on chromosome 6 in dichloroacetic acid and trichloroacetic acid-induced liver tumors in female B6C3F1 mice.
    Tao L; Li K; Kramer PM; Pereira MA
    Cancer Lett; 1996 Nov; 108(2):257-61. PubMed ID: 8973603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High frequency of ras mutations in forestomach and lung tumors of B6C3F1 mice exposed to 1-amino-2,4-dibromoanthraquinone for 2 years.
    Hayashi S; Hong HH; Toyoda K; Ton TV; Devereux TR; Maronpot RR; Huff J; Sills RC
    Toxicol Pathol; 2001; 29(4):422-9. PubMed ID: 11560247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.